TLX
Trans-Lux Corp.
NASDAQ · Healthcare · Biotechnology · AU
$12.59
+0.68%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 159.09x
- P/E 2027E
- 829.08x
- P/E 2028E
- 66.94x
- P/S forward
- 17.77x
Trailing multiples
Trailing twelve months
- P/E TTM
- 127.75x
- PEG TTM
- —
- Price / book
- 8.52x
- Price / sales
- 4.57x
- Price / cash flow
- -312.64x
Enterprise value
- Enterprise value
- $4.6B
- EV / sales
- 4.93x
- EV / EBITDA
- 140.02x
- EV / EBIT
- -641.70x
- Market cap
- $4.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026